| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |